wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52571134-FDDBF6F6-5C58-4D27-AE84-33C41B844DF1
Q52571134-FDDBF6F6-5C58-4D27-AE84-33C41B844DF1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52571134-FDDBF6F6-5C58-4D27-AE84-33C41B844DF1
Correlation of plasma concentration and adverse effects of bosutinib: standard dose or dose-escalation regimens of bosutinib treatment for patients with chronic myeloid leukemia.
P2860
Q52571134-FDDBF6F6-5C58-4D27-AE84-33C41B844DF1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52571134-FDDBF6F6-5C58-4D27-AE84-33C41B844DF1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6f168b3c710cfa9520e350265cfa8781b9c447b0
P2860
Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up.